ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has announced three senior appointments to its newly incorporated subsidiary company, Inaphaea BioLabs (Inaphaea).
Headquartered in MediCity Nottingham, Inaphaea will offer a wide range of pre-clinical and drug discovery testing services to academic, biotech and pharmaceutical researchers, forming the foundation of ValiRx’s tCRO™ (translational Contract Research Organisation) strategy.